| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Longwood Fund II, L.P. last filed a Form 4 in October 2018, as 10% Owner at DCOY.
Longwood Fund II, L.P. has 3 Form 4 filings on record from February 2015 to October 2018, all as 10% Owner at Salarius Pharmaceuticals (DCOY), 2015–2018.
The 4 reported transactions were 2 conversions, 1 open-market sale and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $628K and 1 sale worth about $2.9M.
The only open-market purchase was 89,680 shares of DCOY at an average $7.00 on March 11, 2016, about $628K.
The only open-market sale was 3,212,861 shares of DCOY at an average $0.92 on October 16, 2018, about $2.9M.
Shares as reported in the last Form 4 for each company; the most recent is from October 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.